Foundations Investment Advisors LLC Acquires 9,140 Shares of CVS Health Corporation $CVS

Foundations Investment Advisors LLC grew its holdings in CVS Health Corporation (NYSE:CVS) by 97.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 18,473 shares of the pharmacy operator’s stock after purchasing an additional 9,140 shares during the period. Foundations Investment Advisors LLC’s holdings in CVS Health were worth $1,393,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Avion Wealth boosted its stake in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Capital Advisors Inc. boosted its position in CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 142 shares in the last quarter. Corundum Trust Company INC bought a new stake in shares of CVS Health during the third quarter worth $29,000. Harbor Asset Planning Inc. acquired a new position in shares of CVS Health during the second quarter worth $30,000. Finally, Front Row Advisors LLC lifted its stake in shares of CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 371 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Trading Up 0.1%

NYSE:CVS opened at $74.51 on Friday. CVS Health Corporation has a 52 week low of $53.36 and a 52 week high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The firm’s fifty day moving average is $78.90 and its 200-day moving average is $75.16. The firm has a market cap of $94.59 billion, a P/E ratio of 196.09, a P/E/G ratio of 0.68 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The business had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.09 earnings per share. Equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s payout ratio is currently 700.00%.

Analyst Ratings Changes

A number of brokerages have issued reports on CVS. TD Cowen upped their target price on CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, December 10th. Leerink Partners upped their price objective on CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 16th. Sanford C. Bernstein reiterated a “market perform” rating and set a $91.00 target price on shares of CVS Health in a research report on Tuesday, January 6th. The Goldman Sachs Group upped their price target on shares of CVS Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Finally, JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a report on Wednesday, December 17th. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.82.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.